An open-label, Randomized, Single-dose, 2-Period, "-Treatment Crossover Study to Assess the Bioequivalence of Cinacalcet Capsule (Administered as Six of the 5 mg Cinacalcet Capsules) with 30 mg Commercial Tablet in Healthy Adult Volunteers.

Trial Profile

An open-label, Randomized, Single-dose, 2-Period, "-Treatment Crossover Study to Assess the Bioequivalence of Cinacalcet Capsule (Administered as Six of the 5 mg Cinacalcet Capsules) with 30 mg Commercial Tablet in Healthy Adult Volunteers.

Not stated
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs Cinacalcet (Primary)
  • Indications Secondary hyperparathyroidism
  • Focus Pharmacokinetics
  • Sponsors Amgen
  • Most Recent Events

    • 15 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top